Select publications

aromatase inhibitors in breast cancer management

Pharmacokinetics of anastrozole and tamoxifen alone and in combination during adjuvant endocrine therapy for early breast cancer in postmenopausal women: A sub-protocol of the “Arimidex® and Tamoxifen Alone or in Combination” (ATAC) trial. Br J Cancer 2001; 85(3):317-324. Abstract

Baum M. The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in post-menopausal women. Breast Cancer Res Treat 2001; 69 ( 3 ) :Abstract 8.

Dixon JM et al. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: A randomized, double-blind, single-center study. Clin Cancer Res 2000;6(6):2229-35. Abstract

Dixon JM et al. Lessons from the use of aromatase inhibitors in the neoadjuvant setting. Endocrine-Related Cancer 1999;6(2):227-230. Full Text

Dixon JM et al. Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res Treat 2001; 66:191-9 . Abstract

Ellis MJ et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptorpositive primary breast cancer: Evidence from a phase III randomized trial. J Clin Oncol 2001;19:3808-16. Abstract

Geisler J et al. Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. Clin Cancer Res 2001;7:1230-6. Abstract

Goss PE, Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 2001;19:881-94. Abstract

Hamilton A, Volm M. Nonsteroidal and steroidal aromatase inhibitors in breast cancer. Oncology (Huntingt) 2001;15:965-72;discussion 972, 977-9. Abstract

Ingle JN. Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention. Oncology (Huntingt) 2001; 15:28-34 . Abstract

Milla-Santos A et al. Anastrozole (A) as neoadjuvant (NEO) therapy for hormone-dependent locally advanced breast cancer (LABC) in postmenopausal (PM) patients (pts). Breast Cancer Res Treat 2001; Abstract 302.

Mouridsen H et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001;19:2596-606. Abstract

Nabholtz JM et al. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: Results of a North American multi-center randomized trial. J Clin Oncol 2000;18(22):3758-3767. Abstract

screening mammography

Bomalaski JJ et al. Mammography. Curr Opin Obstet Gynecol 2001; 13 (1) : 15-23. Abstract

Boyd NF et al. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 2001; 3 ( 4 ) : 3 1 4 - 2 1 .Abstract

Chamot E, Perneger TV. Misconceptions about efficacy of mammography screening: A public health dilemma. J Epidemiol Community Health 2001;55(11):799-803. Abstract

Delorme S. Ultrasound mammography and magnetic resonance mammography as adjunctive methods in mammography screening. Radiologe 2001;41(4):371-8. Abstract

Dobias KS et al. Mammography messages in popular media: implications for patient expectations and shared clinical decision-making. Health Expect 2001;4(2):127-35. Abstract

Freer TW, Ulissey MJ. Screening mammography with computer-aided detection: Prospective study of 12,860 patients in a community breast center. Radiology 2001;220(3):781-6. Abstract

Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355(9198):129-34. Abstract

Kerner JF et al. Screening mammography and breast cancer treatment patterns in older women. Breast Cancer Res Treat 2001;69(1):81-91. Abstract

Klabunde CN et al. Quality assurance for screening mammography data collection systems in 22 countries. Int J Technol Assess Health Care 2001;17(4):528-41. Abstract

Moss SM et al. Routine breast screening for women aged 65-69: Results from evaluation of the demonstration sites. Br J Cancer 2001;85:1289-94. Abstract

Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358(9290):1340-2. No Abstract Available.

Olsen O, Gøtzsche PC. Screening for breast cancer with mammography (Cochrane Review). Cochrane Database Syst Rev 2001;4:CD001877. Abstract

Paajanen H et al. The demands of screening mammography on surgical inpatient services of breast cancer. Am Surg 2001;67(7):648-53. Abstract

Scheiden R et al. Consequences of a National Mammography Screening Program on diagnostic procedures and tumor sizes in breast cancer.A retrospective study of 1540 cases diagnosed and histologically confirmed between 1995 and 1997. Pathol Res Pract 2001;197(7):467-74. Abstract

Scinto JD et al. Screening mammography: Is it suitably targeted to older women who are most likely to benefit? J Am Geriatr Soc 2001 ; 49 ( 8 ): 1101-4 . Abstract

Smith RA et al. American Cancer Society guidelines for the early detection of cancer. C A Cancer J Clin 2002;52(1):8-22. Full-Text

Smith TJ et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 1999;17(3):1080-2. Abstract

Woolf SH. The accuracy and effectiveness of routine population screening with mammography, prostate-specific antigen, and prenatal ultrasound: a review of published scientific evidence. Int J Technol Assess Health Care 2001;17(3):275-304. Abstract

Back

Home · Search